MDXH Stock Analysis: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$2.01
0.00 (0.00%)
▲
5d:
-2.43%
30d:
-2.9%
90d:
-43.06%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 14, 2026
5d
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MDXH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: MDXH shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $2.01, which is considered oversold relative to its 30-day fair value range of $2.01 to $2.24.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $1.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.40 (+268.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $1.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.40 (+268.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.01 -
$2.24
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 268.2% below Wall St target ($7.40)
Trading Range Analysis
30-Day Trading Range
$2.01 -
$2.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.95
Resistance Level
$2.23
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.46
Wall Street Target
$7.40
(+268.2%)
Revenue Growth (YoY)
19.4%
Profit Margin
-31.1%
Share & Embed Analysis
Last updated: May 08, 2026 1:49 PM ET
Data refreshes hourly during market hours. Next update: 2:49 PM
Data refreshes hourly during market hours. Next update: 2:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 55 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$128 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$258 | 61 BUY |
